Infant Bacterial Therapeutics AB - Class B

NEW
STU:9IB (Sweden)   Class B
€ 5.99 +0.14 (+2.39%) Jul 24
At Loss
P/B:
10.90
Market Cap:
€ 81.02M ($ 92.17M)
Enterprise V:
€ 69.14M ($ 78.66M)
Volume:
0
Avg Vol (2M):
615.00
Trade In:

Infant Bacterial Therapeutics AB (STU:9IB) Dividend

Infant Bacterial Therapeutics AB (STU:9IB) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:9IB Dividend

Does Infant Bacterial Therapeutics AB (STU:9IB) pay a dividend?

Infant Bacterial Therapeutics AB (STU:9IB) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Infant Bacterial Therapeutics AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Infant Bacterial Therapeutics AB has returned capital to shareholders via buybacks at a rate of -6.3% over the past 3 years.

What are dividend-paying alternatives to Infant Bacterial Therapeutics AB?

For dividend-paying alternatives in Infant Bacterial Therapeutics AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.